Lapaquistat

CAS: 189059-71-0

Ref. 3D-PHA05971

Produktinformation

• Name: Lapaquistat
• Synonyme: 1-[2-[(3R,5S)-7-Chloro-5-(2,3-dimethoxyphenyl)-1,2,3,5-tetrahydro-1-(3-hydroxy-2,2-dimethylpropyl)-2-oxo-4,1-benzoxazepin-3-yl]acetyl]-4-piperidineacetic acid, 4-Piperidineacetic acid, 1-[[(3R,5S)-7-chloro-5-(2,3-dimethoxyphenyl)-1,2,3,5-tetrahydro-1-(3-hydroxy-2,2-dimethylpropyl)-2-oxo-4,1-benzoxazepin-3-yl]acetyl]-, 4-Piperidineacetic acid, 1-[[7-chloro-5-(2,3-dimethoxyphenyl)-1,2,3,5-tetrahydro-1-(3-hydroxy-2,2-dimethylpropyl)-2-oxo-4,1-benzoxazepin-3-yl]acetyl]-, (3R-trans)-, 4-piperidineacetic acid, 1-[2-[(3R,5S)-7-chloro-5-(2,3-dimethoxyphenyl)-1,2,3,5-tetrahydro-1-(3-hydroxy-2,2-dimethylpropyl)-2-oxo-4,1-benzoxazepin-3-yl]acetyl]-, T 91485

Beschreibung

Lapaquistat is a drug that inhibits the activity of protein kinase C-ε, which plays a role in regulating cholesterol synthesis. It also acts as an inhibitor of hydroxyl methyl transferase, which is involved in cholesterol synthesis. This mechanism reduces the production of low-density lipoprotein (LDL) cholesterol and other lipids. Lapaquistat has been shown to be well tolerated in clinical trials and has no significant adverse effects on blood pressure or heart rate. The chemical stability of lapaquistat was demonstrated by its ability to inhibit thp-1 cells in culture for up to 72 hours at temperatures up to 50°C.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 603.1 g/mol
• Formel: C₃₁H₃₉ClN₂O₈
• Reinheit: Min. 95%